Low-Molecular-Weight Heparin versus Unfractionated Heparin in the Treatment of Patients with Acute Pulmonary Thromboembolism

Publisher： Karger

E-ISSN： 1423-0356|69|5|440-444

ISSN： 0025-7931

Source： Respiration, Vol.69, Iss.5, 2002-09, pp. : 440-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 6, 2006-06 ,pp. : 263-268

Karger

Access to resources Recommend Favorite

Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis

By  

Cardiology, Vol. 133, Iss. 3, 2016-0 ,pp. : 163-172

Karger

Access to resources Recommend Favorite